Full Year 2024 Results Key Financial Results Revenue: US$30.8m (down 15% from ...

Q4 2024 Earnings Call Transcript March 31, 2025 Bionano Genomics, Inc. reports earnings inline with expectations. Reported ...

Good day, and welcome to the Bionano fourth quarter 2024 earnings conference call. Today's conference is being recorded. At ...

Discover Bionano Genomics' Q4 2024 earnings insights, focusing on operational efficiency, core customer utilization, and 2025 growth strategies with new ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook ...

Cash, cash equivalents, and available-for-sale securities as of December 31, 2024 were $20.9M, of which $11.4M was subject to certain ...

Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40. The announcement from Bionano ...

This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

Erik Holmlin, PhD, president and chief executive officer of Bionano, added, “Our presence at ACMG 2025 ... rare genetic disorders, and constitutional genomics. We believe the growth in data and ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American College of Medical Genetics and Genomics (ACMG) Annual ...